 |
| DuoNeb® is the only FDA-approved combination medicine for COPD that comes in a single ready-to-use vial for nebulization. DuoNeb® contains albuterol and ipratropium — two of the most commonly prescribed bronchodilators for COPD.
|
 |
| In a third-party market research study of COPD patients, 80% of them said that nebulizing gives them a better quality of life than an MDI alone.1 Nebulizers are fast, effective, and very easy to use. They fit very well with your lifestyle. You can use your nebulizer: |
- at home
- at work
- when you travel
- just about anywhere
|
 |
| DuoNeb® has clear advantages: |
 |
- The combination of medicines in DuoNeb® is more effective and longer lasting than either medicine by itself.
- DuoNeb contains two of the most commonly prescribed medicines for COPD in a single easy-to-use vial. This means no mixing in the pharmacy and less risk of contamination.
- With DuoNeb®, you can receive the same amount of active medicine with up to 45% less solution.*
*DuoNeb® unit dose is 3.0 mL total volume vs 2.5 mL ipratropium unit dose and 3.0 mL albuterol for 5.5 mL total volume.
|
 |
 |
 |
| 1. Patient Assessment of Efficacy of Nebulizer Systems on Their Respiratory Health.Maplewood, NJ: Safian Communications Inc.; 1995. |
 |
| 2. Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines. Chest. 2005;127:335-371. |
|
 |
|
 |